# The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

> **NCT03038035** · PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 150 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** MLC901
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03038035
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-06
- **Final completion:** 2019-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038035, "The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03038035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*